What amount sold does HealthScripts of America - North Louisiana, LLC report in Form D filings?

The latest linked filings report $170K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was HealthScripts of America - North Louisiana, LLC's most recent SEC filing?

HealthScripts of America - North Louisiana, LLC's most recent Form D filing was on 2013-10-31.

How many investors does HealthScripts of America - North Louisiana, LLC have?

The most recent Form D filing lists 24 investor(s).

What type of securities does HealthScripts of America - North Louisiana, LLC offer?

HealthScripts of America - North Louisiana, LLC's SEC Form D filings indicate equity offerings.

HealthScripts of America - North Louisiana, LLC

CIK: 0001590460·Pharmaceuticals·BELLAIRE, TX·Limited Liability Company·Founded 2013

Reported Sold

$170,000

Total Filings

Identified Offerings

Last Filed

Oct 31, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Oct 31, 2013Form D — New notice

Reported sold: $170,000 · Target: $200,000

Rule 506(b)·24 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$170,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kamran Nezami

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 31, 2013	New	$200,000	$170,000	24

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

FibroBiologics, Inc.

Pharmaceuticals

Offering target: $1,200,000

Filed Oct 13, 2026